ArticleArthroplasty today2025
Association Between Routine Patient-Reported Outcome Measure Utilization Among Total Joint Arthroplasty Surgeons and Clinically Meaningful Outcome Achievement.
Article in Arthroplasty today, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cross-cultural adaptation and psychometric validation of the first Arabic KOOS-12: a reliable tool for assessing knee outcomes in Arabic-speaking populations.Knee surgery & related research · 2026Article
- Translation, cross-cultural adaptation, and validation of the Arabic Quebec Back Pain Disability Scale (QBPDS-AR) for patients with lower back pain: a prospective cross-sectional observational study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient-reported outcome measures (PROMs) assess quality of care after total joint arthroplasty (TJA) and will be mandatory for reporting by 2027 under the Center for Medicare and Medicare Services. This study evaluated the impact of PROM utilization on achieving minimum clinically important differences (MCID), substantial clinical benefits (SCB), and patients' global impression of change (PGIC) in primary TJA patients. Methods: The study included 7,441 primary TJA patients (4,458 THAs, 2,983 TKAs) who completed preoperative PROMs within 180 days before surgery and postoperative PROMs 270-450 days after surgery. Surgeons were categorized as PROM users or nonusers based on responses to a survey question about how often they referenced preoperative PROMs before recommending surgery. The primary outcome was the proportion of patients achieving MCID, SCB, or reporting at least "much improved" on the PGIC at 1 year. Multiple linear regression was adjusted for patient age, sex, and BMI. Results: Among TKA patients, PROM users were more likely to achieve SCB (p<0.001; p=0.002), but no significant difference was found for MCID or PGIC. For THA, there were no significant differences between surgeon groups in achieving these measures. Conclusions: TKA patients whose surgeons referenced PROMs were more likely to achieve SCB, suggesting potential benefits of PROM utilization in this group. The lack of effect in THA may reflect the more predictable satisfaction levels in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.